Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review

Yasna Rostam-Abadi, Jaleh Gholami, Maral Mardaneh Jobehdar, Maryam Ardeshir, Ardavan Mohammad Aghaei, Sogol Olamazadeh, Mahshid Taj, Khalid Saeed, Ramin Mojtabai, Afarin Rahimi-Movaghar

Research output: Contribution to journalReview articlepeer-review

Abstract

Drug use is an increasing global public health concern. We reviewed the prevalence and patterns of drug use, drug use disorders, and the extent of treatment services in 21 countries and one territory in the Eastern Mediterranean region from 2010 to 2022. Online databases were systematically searched on April 17, 2022, along with other sources for grey literature. The extracted data were analysed and used for synthesis at the country, subregional, and regional levels. The prevalence of drug use is higher in the Eastern Mediterranean region than global estimates, with cannabis, opium, khat, and tramadol among the main drugs used in the region. Data on the prevalence of drug use disorders were scarce and heterogeneous. Treatment facilities for drug use disorders are available in most countries, but opioid agonist treatment exists in only seven countries. There is a need to expand evidence-based and cost-effective care. Limited data exist, especially regarding drug use disorders, treatment coverage, and drug use among women and young people.

Original languageEnglish (US)
Pages (from-to)282-295
Number of pages14
JournalThe Lancet Psychiatry
Volume10
Issue number4
DOIs
StatePublished - Apr 2023

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Drug use, drug use disorders, and treatment services in the Eastern Mediterranean region: a systematic review'. Together they form a unique fingerprint.

Cite this